Gerber Extensive HA Powder Infant Formula - 5000048519 - 6 Each - MDL-NCL48519
Good Start Extensive HA Formula, 14.1 oz.TRUE Clinically proven to be hypoallergenic and promote adequate...
Price :
Regular price
$583.99
Regular price
$583.99
Good Start Extensive HA Formula, 14.1 oz.TRUE
- Clinically proven to be hypoallergenic and promote adequate growth100% whey protein extensively hydrolyzed
- Clinically shown to delivers a plasma amino acid profile similar to breast milk1-4
- Probiotic B. lactis to help promote a balanced microbiota5
- 49% MCT to facilitate fat absorption6,7
- DHA for brain and eye development8-12
- Osmolality of 220 mOsm/kg water, close to breast milk
1. American Academy of Pediatrics Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics. 2000;106:346-349.2. Hypoallergenicity. Data on file. Nestlé. 2014.3. Janas JM et al. Indices of protein metabolism in term infants fed either human milk or formulas with reduced protein concentration and various whey/casein ratios. J Pediatr. 1987;110:838-848.4. Plasma amino acid values. Data on file. Nestlé. 2014.5. Hol J et al. The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial. J Allergy Clin Immunol. 2008;121:1448-1454.6. Bach AC et al. Medium-chain triglycerides: an update. Am J Clin Nutr. 1982;36:950-962.7. Ruppin DC et al. Clinical use of medium chain triglycerides. Drugs.1989;20:216-224.8. Birch EE et al. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res. 1998;44:201 209.9. Birch EE et al. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000;42:174-181.10. Hoffman DR et al. Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development. J Pediatr Gastroenterol Nutr. 2000;31:540-553.11. Koletzko B et al. Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development. Acta Paediatr. 2001;90:460-464.12. Uauy R et al. Essential fatty acids in early life: structural and functional role. Proc Nutr Soc. 2000;59:3-15.
1. American Academy of Pediatrics Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics. 2000;106:346-349.2. Hypoallergenicity. Data on file. Nestlé. 2014.3. Janas JM et al. Indices of protein metabolism in term infants fed either human milk or formulas with reduced protein concentration and various whey/casein ratios. J Pediatr. 1987;110:838-848.4. Plasma amino acid values. Data on file. Nestlé. 2014.5. Hol J et al. The acquisition of tolerance toward cow's milk through probiotic supplementation: a randomized, controlled trial. J Allergy Clin Immunol. 2008;121:1448-1454.6. Bach AC et al. Medium-chain triglycerides: an update. Am J Clin Nutr. 1982;36:950-962.7. Ruppin DC et al. Clinical use of medium chain triglycerides. Drugs.1989;20:216-224.8. Birch EE et al. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res. 1998;44:201 209.9. Birch EE et al. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000;42:174-181.10. Hoffman DR et al. Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development. J Pediatr Gastroenterol Nutr. 2000;31:540-553.11. Koletzko B et al. Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development. Acta Paediatr. 2001;90:460-464.12. Uauy R et al. Essential fatty acids in early life: structural and functional role. Proc Nutr Soc. 2000;59:3-15.